Melissa Loseke, the chief medical officer for Re-new Institute, said she voted yes to recommending Emideltide based on the evidence provided and because there is a legitimate role in individualized patient care that FDA products do not fully serve at this time. While the Food and Drug Administration has a final say on whether the select peptides can be compounded, the agency traditionally weighs the committees advice to make its decision
Services are available in all 50 US states through our affiliated medical providers and pharmacy partners." Its terms of use, separately, say "certain of our Services are currently only available to individuals located in certain states" - a more limited, general disclaimer
Robert T Morris, MD Specialties: Obstetrics & Gynecology, Gynecologic Oncology Services: Cervical Cancer, Endometrial Cancer , Ovarian Cancer , Uterine Cancer , Vaginal Cancer , Vulvar Cancer , Cancer Surgery Board Certification and Education Board Certifications American Board of Obstetrics & Gynecology - Gynecologic Oncology American Board of Obstetrics & Gynecology - Obstetrics and Gynecology Education Wayne State University, MI, 1997 Wayne State University, Cancer Biology, MI, 1992 University of Minnesota, MN, 1988 Residencies & Internships Wayne State University, MI, 1994 Wayne State University, Obstetrics and Gynecology, MI, 1990 Fellowship University of Texas - MD Anderson Cancer Center, Oncology Gynecologic, TX, 1996 About Me Languages Gender Videos and Articles Videos Blog Posts Locations Hospital Privileges Henry Ford St
both are unapproved research chemicals (assigned 503A Category 2 and difficult to compound)
